Form 4: Director Richard Nigon Receives Celcuity Equity Grant

Director Richard Nigon acquired 1,530 restricted stock units in Celcuity Inc. as part of an equity compensation arrangement.

Summary

• Director Richard Nigon was granted 1,530 restricted stock units (RSUs) of Celcuity Inc. common stock.
• The transaction occurred on June 5, 2026.
• The RSUs were granted at a price of $0 per share as part of director compensation.
• Following this transaction, Richard Nigon's total beneficial ownership in the company increased to 80,565 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increase in total beneficial ownership by a member of the board.

Negatives

• None identified.

Risks

• Standard market risks associated with equity ownership in a biotechnology company.

Future Outlook

The restricted stock units are scheduled to vest on the earlier of the 2027 annual meeting of stockholders or April 30, 2027.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the biotechnology sector to ensure long-term alignment between board members and shareholders.

Comparison to Industry Standards

• The grant of restricted stock units as director compensation is consistent with standard practices for small-cap biotechnology firms.
• The vesting schedule tied to annual meetings is a common retention mechanism used by peer companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity compensation event.

Next Steps

• Vesting of the 1,530 restricted stock units by April 30, 2027, or the 2027 annual meeting.

Key Dates

Keywords

Celcuity, CELC, Form 4, Insider Trading, Director Compensation, Equity Grant